Outpatient step-up dosing of bispecific antibodies in relapsed or refractory multiple myeloma: an oncology nursing framework for monitoring and supportive care - Top-Institutions - MDSpire

Outpatient step-up dosing of bispecific antibodies in relapsed or refractory multiple myeloma: an oncology nursing framework for monitoring and supportive care

  • By

  • Yanfeng Song

  • Xiaofei Zhou

  • Lina Wang

  • June 9, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Center
    Dana-Farber Cancer Center

    Boston, Massachusetts

    Key Differentiators

    • Oncology Nursing
    • Hematology

  • #2

    Mayo Clinic Comprehensive Cancer Center
    Mayo Clinic Comprehensive Cancer Center

    Rochester, Minnesota

    Key Differentiators

    • Oncology Nursing
    • Hematology

  • #3

    Brigham and Women’s Cancer Center
    Brigham and Women’s Cancer Center

    Boston, Massachusetts

    Key Differentiators

    • Oncology Nursing
    • Hematology

  • #4

    Jerome Lipper Multiple Myeloma Center
    Jerome Lipper Multiple Myeloma Center

    Boston, Massachusetts

    Key Differentiators

    • Oncology Nursing
    • Hematology

  • #5

    LeBow Institute for Myeloma Therapeutics
    LeBow Institute for Myeloma Therapeutics

    Boston, Massachusetts

    Key Differentiators

    • Oncology Nursing
    • Hematology

Original Source(s)

Outpatient step-up dosing of bispecific antibodies in relapsed or refractory multiple myeloma: an oncology nursing framework for monitoring and supportive care

  • by Yanfeng Song, Xiaofei Zhou, Lina Wang

  • June 9, 2026

Related Content

The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy

Differential expression of immune activation markers in T cells from patients with multiple myeloma

Using period analysis to timely provide serial data on long-term survival for patients with hematological malignancies from Taizhou, Eastern China